Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis

NAActive, not recruitingINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

February 29, 2024

Study Completion Date

June 30, 2029

Conditions
Aortic Valve StenosisCardiovascular DiseasesHeart DiseasesHeart Valve DiseasesVentricular Outflow Obstruction
Interventions
DEVICE

Transcatheter aortic valve replacement

Retrograde transfemoral transcatheter aortic valve replacement with any CE mark approved aortic bioprosthesis with or without concomitant percutaneous coronary intervention.

DEVICE

Surgical aortic valve replacement

Conventional surgical aortic valve replacement with a bioprosthesis using normothermic cardiopulmonary bypass and cold blood cardioplegia cardiac arrest with or without concomitant coronary artery bypass graft surgery.

Trial Locations (9)

101

Landspital, Reykjavik

2100

Rigshospitalet, Copenhagen University Hospital, Copenhagen

5021

Haukeland University Hospital, Bergen

8000

Aarhus University hospital, Aarhus

20520

Turku University Hospital, Turku

90220

Oulu University Hospital, Oulu

FI00029

Helsinki University Central Hospital, Helsinki

413 45

Sahlgrenska University Hospital, Gothenburg

171 76

Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Symetis SA

INDUSTRY

collaborator

Boston Scientific Corporation

INDUSTRY

collaborator

Abbott

INDUSTRY

collaborator

Edwards Lifesciences

INDUSTRY

lead

Ole De Backer

OTHER